The effectiveness of intracytoplasmic sperm injection combined with piezoelectric stimulation in infertile couples with total fertilization failure
Fertility and Sterility, cilt.94, sa.3, ss.900-904, 2010 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 94 Sayı: 3
- Basım Tarihi: 2010
- Doi Numarası: 10.1016/j.fertnstert.2009.03.107
- Dergi Adı: Fertility and Sterility
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.900-904
- Anahtar Kelimeler: electrical activation, embryo grade, fertilization rate, ICSI, pregnancy
- Ankara Üniversitesi Adresli: Evet
Özet
Objective: To assess the effectiveness of intracytoplasmic sperm injection (ICSI) combined with piezoelectric stimulation in infertile couples with a history of total fertilization failure (TFF). Design: Prospective controlled trial. Setting: Clinical IVF laboratory. Patient(s): Seventy-one couples undergoing ICSI on sibling oocytes having at least one previous ICSI attempt with TFF. Intervention(s): ICSI or ICSI with piezoelectric activation. Main Outcome Measure(s): Fertilization rate. Result(s): The patients were allocated to two groups: group I included 21 patients with only one previous TFF and group II included 50 patients with more than one previous TFF. Collectively, a total of 823 metaphase II (MII) oocytes were retrieved in 78 oocyte retrievals. In Group I, combined ICSI with piezoelectric stimulation was applied to 123/211 (58.2%) of MII oocytes (group IA), whereas standard ICSI procedure was applied to 88/211 (41.8%) of MII oocytes (group IB). The fertilization rate was 62% and 12% in group IA and group IB respectively. In group II, piezoelectric activation was applied in all 612 MII oocytes, of which 296 (48.3%) were fertilized. The rates for implantation and pregnancy/embryo transfer were obtained as 30.6% and 44.1%, respectively. Conclusion(s): Piezoelectric activation seems to improve IVF outcome in patients with previous TFF history. © 2010 by American Society for Reproductive Medicine.